Acadia Healthcare Company, Inc. filed a current report on Form 8-K with the SEC on November 4, 2026, announcing the release of its operating and financial results for the third quarter ended September 30, 2026, and disclosing plans for a related investor conference call.

Key Highlights

  • Filing date: November 4, 2026, covering the quarter ended September 30, 2026.
  • Exchange and ticker: Common Stock ($0.01 par value) listed on NASDAQ:ACHC.
  • Conference call scheduled: November 5, 2026 at 9:00 a.m. Eastern Time to discuss third quarter 2026 financial results.
  • Exhibits furnished: A press release (Exhibit 99.1) and a slide presentation (Exhibit 99.2), both dated November 4, 2026.
  • Signing officer: David Duckworth, Interim Chief Financial Officer, signed the report on behalf of the registrant.
  • Operations scope: According to the filing, the company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers, and outpatient behavioral healthcare facilities throughout the U.S. and Puerto Rico.

Acadia Healthcare Furnishes Q3 2026 Earnings Materials and Investor Call Details

Acadia Healthcare Company, Inc., a Delaware holding company headquartered at 4020 Aspen Grove Drive, Suite 900, Franklin, Tennessee, filed this current report under Items 2.02 and 7.01 of Form 8-K. Item 2.02 covers results of operations and financial condition, while Item 7.01 pertains to Regulation FD disclosure. The filing states that the company issued a press release on November 4, 2026, announcing "among other things, the Company's operating and financial results for the third quarter ended September 30, 2026." That press release was furnished as Exhibit 99.1 and incorporated by reference into the report.

Under Item 7.01, the filing discloses that company representatives planned to conduct a conference call on November 5, 2026, and that they "may refer to information described on the slides furnished with this Current Report" as Exhibit 99.2. The filing notes that the information furnished under both Items 2.02 and 7.01 "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934." The report was signed by David Duckworth in his capacity as Interim Chief Financial Officer.

The filing's forward-looking statements section identifies several risk factors specific to the company's business, including the potential impact of "significant changes to Medicaid financing mechanisms introduced by the One Big Beautiful Bill Act (the 'OBBBA') enacted on July 4, 2025," possible reductions in government and commercial payor payments, and risks related to cybersecurity incidents and labor costs. The filing states these are the company's own forward-looking statements and that the company "does not undertake to update or revise any forward-looking statements."

What Was Disclosed

Acadia Healthcare filed an 8-K on November 4, 2026, furnishing its third quarter 2026 earnings press release and an investor slide presentation as exhibits, and announcing an earnings conference call scheduled for November 5, 2026 at 9:00 a.m. Eastern Time.